Annual Operating Expenses
$15.47 M
-$21.90 M-58.60%
31 December 2023
Summary:
Aprea Therapeutics annual total operating expenses is currently $15.47 million, with the most recent change of -$21.90 million (-58.60%) on 31 December 2023. During the last 3 years, it has fallen by -$21.97 million (-58.68%). APRE annual operating expenses is now -70.70% below its all-time high of $52.81 million, reached on 31 December 2020.APRE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$4.10 M
+$250.10 K+6.50%
30 September 2024
Summary:
Aprea Therapeutics quarterly total operating expenses is currently $4.10 million, with the most recent change of +$250.10 thousand (+6.50%) on 30 September 2024. Over the past year, it has increased by +$422.10 thousand (+11.49%). APRE quarterly operating expenses is now -81.75% below its all-time high of $22.45 million, reached on 30 June 2022.APRE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APRE Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +11.5% |
| 3 y3 years | -58.7% | -47.7% |
| 5 y5 years | -47.6% | -65.8% |
APRE Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.7% | at low | -81.8% | +54.5% |
| 5 y | 5 years | -70.7% | at low | -81.8% | +54.5% |
| alltime | all time | -70.7% | >+9999.0% | -81.8% | +54.5% |
Aprea Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.10 M(+6.5%) |
| June 2024 | - | $3.85 M(+22.1%) |
| Mar 2024 | - | $3.15 M(-14.3%) |
| Dec 2023 | $15.47 M(-58.6%) | $3.67 M(+4.3%) |
| Sept 2023 | - | $3.52 M(-3.5%) |
| June 2023 | - | $3.65 M(-21.0%) |
| Mar 2023 | - | $4.62 M(+74.3%) |
| Dec 2022 | $37.37 M(-0.2%) | $2.65 M(-36.9%) |
| Sept 2022 | - | $4.20 M(-81.3%) |
| June 2022 | - | $22.45 M(+178.0%) |
| Mar 2022 | - | $8.07 M(+3.1%) |
| Dec 2021 | $37.45 M(-29.1%) | $7.83 M(-17.0%) |
| Sept 2021 | - | $9.43 M(-5.7%) |
| June 2021 | - | $10.00 M(-1.9%) |
| Mar 2021 | - | $10.19 M(-28.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $52.81 M(+78.8%) | $14.22 M(+16.3%) |
| Sept 2020 | - | $12.23 M(-15.5%) |
| June 2020 | - | $14.48 M(+22.0%) |
| Mar 2020 | - | $11.87 M(-0.9%) |
| Dec 2019 | $29.54 M(+79.2%) | $11.98 M(+66.0%) |
| Sept 2019 | - | $7.22 M(+21.6%) |
| June 2019 | - | $5.94 M(+34.7%) |
| Mar 2019 | - | $4.41 M(-10.0%) |
| Dec 2018 | $16.49 M(+4.0%) | $4.90 M(+67.2%) |
| Sept 2018 | - | $2.93 M |
| Dec 2017 | $15.85 M(+391.7%) | - |
| June 2008 | $3.22 M(-44.1%) | - |
| June 2007 | $5.77 M(-34.3%) | - |
| June 2006 | $8.79 M(>+9900.0%) | - |
| Dec 2004 | $7800.00 | - |
FAQ
- What is Aprea Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly operating expenses year-on-year change?
What is Aprea Therapeutics annual total operating expenses?
The current annual operating expenses of APRE is $15.47 M
What is the all time high annual operating expenses for Aprea Therapeutics?
Aprea Therapeutics all-time high annual total operating expenses is $52.81 M
What is Aprea Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of APRE is $4.10 M
What is the all time high quarterly operating expenses for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly total operating expenses is $22.45 M
What is Aprea Therapeutics quarterly operating expenses year-on-year change?
Over the past year, APRE quarterly total operating expenses has changed by +$422.10 K (+11.49%)